基因表达谱分析用于日本流感疫苗与佐剂下一代安全性控制
本文综述了日本流感疫苗安全性控制的现状,指出动物安全性试验数十年来的贡献与改进需求,并介绍了基于cDNA微阵列技术鉴定与体重和白细胞计数变化相关的17个标志基因,这些基因表达谱有望成为多种流感疫苗安全性控制的替代指标。
要点
- 动物安全性试验用于监测临床试验用疫苗与市售疫苗间质量一致性,评估体重和白细胞计数等生物学反应变化。
- 从灭活全病毒流感疫苗处理动物的肺组织中分析超过10000个基因的表达谱,鉴定出17个与体重和白细胞计数变化相关的标志基因。
- 标志基因表达谱有望作为高灵敏度、短周转时间的替代指标,用于多种流感疫苗的安全性控制。
核心结论
- 标志基因表达谱有望成为多种流感疫苗安全性控制的替代指标,提供高灵敏度和短周转时间。
- 基因表达谱分析可能成为未来疫苗安全性控制的有力工具。
研究设计与样本
- 原文未报告
主要发现
- 从灭活全病毒流感疫苗处理动物的肺组织中分析超过10000个基因的表达谱,鉴定出17个标志基因,其表达模式与接种动物的体重和白细胞计数变化良好相关。
- 在生物学反应变化轻微的流感HA疫苗处理动物中,发现标志基因的稳健表达模式。
- 这些标志基因也可用于佐剂流感疫苗的评价。
关键数值与推荐
- 原文未报告
临床怎么用
- 原文未据此给出推荐
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Influenza becomes epidemic worldwide every year, and many individuals receive vaccination annually. Quality control relating to safety and potency of influenza vaccines is important to maintain public confidence. The safety of influenza vaccines has been assessed by clinical trials, and animal safety tests are performed to monitor the consistent quality between vaccines used for clinical trials and marketing; the biological responses in vaccinated animals are evaluated, including changes in body weight and white blood cell count. Animal safety tests have been contributing to the quality relating to the safety of influenza vaccines for decades, but improvements are needed. Although precise mechanisms involving biological changes in animal safety tests have not been fully elucidated, the application of cDNA microarray technology make it possible to reliably identify genes related to biological responses in vaccinated animals. From analysis of the expression profile of >10,000 genes of lung in animals treated with an inactivated whole virion influenza vaccine, we identified 17 marker genes whose expression patterns correlated well to changes in body weight and leukocyte count in vaccinated animals. In influenza HA vaccine-treated animals exhibiting subtle changes in biological responses, a robust expression pattern of marker genes was found. Furthermore, these marker genes could also be used in the evaluation of adjuvanted influenza vaccines. The expression profile of marker genes is expected to be an alternative indicator for safety control of various influenza vaccines conferring high sensitivity and short turnaround time. Thus, gene expression profiling may be a powerful tool for safety control of vaccines in the future.
引用
- Momose H, Sasaki E, Kuramitsu M, et al. Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan. Vaccine. 2018. PMID: 30243500. doi:10.1016/j.vaccine.2018.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。